You have 9 free searches left this month | for more free features.

Excess Glucocorticoid

Showing 1 - 25 of 1,726

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adrenocortical Carcinoma Trial in United States (Relacorilant, Pembrolizumab)

Recruiting
  • Adrenocortical Carcinoma
  • Stanford, California
  • +5 more
Jun 27, 2022

Adult Glucocorticoid Excess, Adult Adrenal Insufficiency Trial (Biological samples, Complications)

Not yet recruiting
  • Adult Glucocorticoid Excess
  • Adult Adrenal Insufficiency
  • Biological samples
  • Complications
  • (no location specified)
Dec 20, 2021

Glucocorticoid Withdrawal Syndrome in Treated Cushing Syndrome

Recruiting
  • Cushing Syndrome
  • MUSE biofeedback
  • Rochester, Minnesota
    Mayo Clinic
Oct 31, 2022

Uveitis, Metformin, Glucocorticoid Trial in Tianjin (Metformin, Placebo)

Recruiting
  • Uveitis
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Eye Hospital
May 5, 2022

Iatrogenic Cushing Disease Trial in London (Metformin, Placebo)

Completed
  • Iatrogenic Cushing Disease
  • London, United Kingdom
    Barts and the London
Jan 14, 2019

Prevalence of Hidden Hypercortisolism in Osteoporosis

Recruiting
  • Osteoporosis
  • Cortisol Excess
    • Catania, Italy
    • +4 more
    Mar 8, 2023

    Congenital Adrenal Hyperplasia Trial in Naples (Conventional Glucocorticoids (immediate release hydrocortisone, cortisone

    Recruiting
    • Congenital Adrenal Hyperplasia
    • Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
    • Dual release hydrocortisone (plenadren)
    • Naples, Italy
      Federico II University
    Mar 21, 2022

    Does Relative Hypoglycaemia &/or Sleep Disturbance Contribute to

    Recruiting
    • Addison Disease
    • Blood test
    • Leeds, United Kingdom
      The Leeds Teaching Hospital NHS Trust
    Aug 24, 2022

    Anorexia Nervosa, Stress Trial

    Not yet recruiting
    • Anorexia Nervosa
    • Stress
      • (no location specified)
      Jun 27, 2023

      Giant Cell Arteritis Trial in Worldwide (Sarilumab SAR153191, Sarilumab matching , Prednisone)

      Terminated
      • Giant Cell Arteritis
      • Sarilumab SAR153191
      • +3 more
      • Boca Raton, Florida
      • +60 more
      Mar 15, 2022

      Iatrogenic Cushing's Disease Trial in Oxford (AZD4017 and prednisolone, Placebo Oral Tablet and prednisolone)

      Completed
      • Iatrogenic Cushing's Disease
      • AZD4017 and prednisolone
      • Placebo Oral Tablet and prednisolone
      • Oxford, United Kingdom
        University of Oxford
      May 12, 2021

      Novel Mediators of Lipodystrophy and Metabolic Consequences of

      Completed
      • Cushing's Syndrome
      • Treatment of Cushing's
      • New York, New York
        Columbia University Neuroendocrine Unit
      Jul 12, 2021

      Graves Ophthalmopathy Trial in Sofia (Methylprednisolone)

      Completed
      • Graves Ophthalmopathy
      • Sofia, Bulgaria
        University Hospital of Endocrinology
      Mar 29, 2023

      Gonadal Changes In Congenital Adrenal Hyperplasia Patients

      Recruiting
      • Congenital Adrenal Hyperplasia
      • Ultrasonography and MRI
      • Cairo, Egypt
        Ain Shams University
      Dec 10, 2021

      Knee Osteoarthritis Trial (Sinomenine, Glucocorticoid)

      Not yet recruiting
      • Knee Osteoarthritis
      • (no location specified)
      Mar 1, 2023

      Healthy Trial in Aarhus (Prednisolone)

      Recruiting
      • Healthy
      • Aarhus, State, Denmark
        Department of Endocrinology and Internal Medicine
      Sep 6, 2023

      Study of Adrenal Gland Tumors

      Completed
      • Adrenal Gland Neoplasm
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

        Recruiting
        • Castration-Resistant Prostate Carcinoma
        • +4 more
        • Computed Tomography
        • +3 more
        • San Francisco, California
          University of California San Francisco
        Dec 19, 2022

        Reduced-dose Alemtuzumab for Kidney Transplant Rejection

        Not yet recruiting
        • Kidney Transplant Rejection
          • (no location specified)
          Oct 25, 2023

          Inflammatory Cardiomyopathy, Myocarditis Trial in Wuhan (Hydroxychloroquine, Prednisolone)

          Recruiting
          • Inflammatory Cardiomyopathy
          • Myocarditis
          • Wuhan, Hubei, China
            Tongji Hospital
          Jul 18, 2023

          Insulin Resistance, Non-Alcoholic Fatty Liver Disease Trial in Hellerup (Curcumin Liposome, Prednisolone, Placebos)

          Terminated
          • Insulin Resistance
          • Non-Alcoholic Fatty Liver Disease
          • Curcumin Liposome
          • +2 more
          • Hellerup, Denmark
            Center for Clinical Metabolic Research
          Apr 4, 2022

          IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)

          Recruiting
          • IgG4-related Disease With Eosinophilia
          • Beijing, Bejing, China
            Peking Union Medical College Hospital
          Mar 23, 2023

          Giant Cell Arteritis Trial (Secukinumab 300 mg, s.c., Placebo to match Secukinumab, s.c.)

          Recruiting
          • Giant Cell Arteritis
          • Secukinumab 300 mg, s.c.
          • Placebo to match Secukinumab, s.c.
          • Berlin, Germany
          • +2 more
          Oct 12, 2022

          High Dose Glucocorticoid Steroids on Myocardial Function

          Completed
          • High-dose Steroids, Myocardial Function, Longitudinal Strain
            • Hadera, Israel
              Hillel Yaffe Hospital
            Nov 30, 2020

            Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

            Not yet recruiting
            • Immune Thrombocytopenia
            • Treatment
            • Obinutuzumab Injection [Gazyva]
            • Tianjin, China
              Institute of Hematology and Blood Diseases Hospital, Chinese Aca
            Oct 17, 2023